You are here: Industry Insights > COVID-19

News List

COVID-19 is benefiting contract manufacturing services, suggest reports europeanpharmaceuticalreview
November 19, 2020
Reports have found that the COVID-19 pandemic is providing new opportunities for contract and development manufacturing organisations (CDMOs).
Drug Safety Research Unit says repurposed drugs for COVID-19 still require a lot of testing europeanpharmaceuticalreview
November 19, 2020
The DSRU said that global collaboration would be required to successfully expedite the necessary safety and efficacy evaluations for repurposed drugs to be used in COVID-19 patients.
Almac Gets Grant From COVID-19 Therapeutics Accelerator contractpharma
November 19, 2020
?Almac Sciences has been awarded a grant of approximately $500,000 by the COVID-19 Therapeutics Accelerator towards developing cost effective, scalable processes for the production of the active pharmaceutical ingredient (API) of the drug remdesivir.
Sinovac’s CoronaVac triggers quick immune response in Covid-19 trial pharmaceutical-technology
November 19, 2020
Sinovac Biotech has reported the preliminary results from Phase I/II trial that showed its experimental Covid-19 vaccine, CoronaVac, triggered a quick immune response in healthy adults.
RedHill Biopharma to initiate Phase II/III trial of Covid-19 candidate pharmaceutical-technology
November 19, 2020
RedHill Biopharma is set to start the Phase II/III study evaluating orally administered RHB-107 (upamostat) in patients with symptomatic Covid-19 who do not require hospitalisation.
NSRT to conduct phase II trials of Eflornithine to treat COVID-19 expresspharma
November 19, 2020
The trials will be conducted in four cities namely; Delhi, Lucknow, Pune, and Bengaluru and the company aims to complete the study in three to four months.
Cipla signs licensing pact with MultiG for COVID-19 rapid antibody test kit expresspharma
November 19, 2020
'Covi-G' has been commercialised in 20+ countries, with sensitivity and specificity exceeding 92 per cent, informs company.
WHO lists first vaccine for emergency use europeanpharmaceuticalreview
November 18, 2020
The nOPV2 vaccine has received emergency use listing and will be used to combat outbreaks of circulating vaccine-derived polio viruses (cVDPVs).
Vicore Pharma recruits the first patient in the phase 2 proof-of-concept study in idiopathic pulmonary fibrosis pharmaceutical-business-review
November 18, 2020
Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, announces that the first patient in the phase II idiopathic pulmonary fibrosis (IPF) study has been recruited in India.
New inquiry launched to assess impact of pandemic on pharmacy services pharmatimes
November 18, 2020
The All-Party Parliamentary Group on Pharmacy have launched an inquiry into the financial and operational impacts of the COVID-19 pandemic on pharmacy services in the UK.